Compare Fastenal Company Common Stock (FAST) vs Halozyme Therapeutics Inc. Common Stock (HALO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Fastenal Company Common Stock vs Halozyme Therapeutics Inc. Common Stock — how do they compare? Fastenal Company Common Stock trades at $50.72 (market cap $57.94B), while Halozyme Therapeutics Inc. Common Stock trades at $110.59 (market cap $12.58B). The key difference: Fastenal Company Common Stock is far larger — about 4.6× Halozyme Therapeutics Inc. Common Stock's market cap, and Fastenal Company Common Stock pays a 1.9% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Fastenal Company Common Stock for 1 Days and Halozyme Therapeutics Inc. Common Stock for 1 Days on average.
| FAST | HALO | |
|---|---|---|
Market Cap | $57.94B | $12.58B |
Volume | 6,764,575 | 2,179,278 |
Sector | Industrials | Health |
52-Week High | $52.38 | $115.22 |
52-Week Low | $39.15 | $61.63 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $58.17B | $14.49B |
Dividend Yield | 1.9% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Fastenal Company Common Stock
Fastenal distributes fasteners, tools, safety supplies, and other industrial products. It also provides inventory management and vending solutions for business customers.
Read more on FAST →About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →
